ARCHIVES

SWOG Restarts Gynecologic Malignancies Committee.

This article is from The Cancer Letter archive.

Vol. 34 No. 19 | May 16, 2008

Download PDF Visit The Full Archive

Related Articles

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013